Positron Emission Tomography and Sentinel Lymph Node Dissection in Breast Cancer
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3 (1) , 73-77
- https://doi.org/10.3816/cbc.2002.n.014
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- In vitro B-mode ultrasonographic criteria for diagnosing axillary lymph node metastasis of breast cancer.Journal of Ultrasound in Medicine, 1999
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.Radiology, 1997
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJNCI Journal of the National Cancer Institute, 1996
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- CT-Pathologic Correlation of Axillary Lymph Nodes in Breast CarcinomaJournal of Computer Assisted Tomography, 1991
- Lack of efficacy of xeroradiography to preoperatively detect axillary lymph node metastases in breast cancerBreast Cancer Research and Treatment, 1983
- ENLARGED MASTECTOMY FOR BREAST CANCERAmerican Journal of Roentgenology, 1971
- Radical Mastectomy for Mammary CarcinomaAnnals of Surgery, 1969